| 0.2 |
0.6 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.2 |
0.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.4 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
0.6 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.1 |
0.7 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.4 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 |
0.3 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
1.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.4 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.6 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.2 |
GO:0031106 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.1 |
0.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.2 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.0 |
0.3 |
GO:1902963 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.0 |
0.3 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.0 |
0.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.1 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.0 |
0.7 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 |
0.2 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
0.7 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.0 |
0.3 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.1 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.0 |
0.1 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
0.8 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.0 |
0.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.1 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.0 |
0.5 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.0 |
0.1 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 |
0.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.1 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.0 |
0.1 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.0 |
0.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.1 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
0.1 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.0 |
0.1 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.0 |
0.1 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 |
0.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.2 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.0 |
0.2 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.1 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.0 |
0.1 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 |
0.1 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.0 |
0.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.1 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.0 |
0.2 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 |
0.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.3 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 |
0.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.1 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
0.0 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.0 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 |
0.2 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.1 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.0 |
0.1 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.0 |
0.1 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.0 |
0.0 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.0 |
0.1 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.0 |
0.2 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.0 |
0.6 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.1 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.0 |
0.4 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.0 |
0.0 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.0 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.0 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.0 |
0.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.1 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.0 |
0.0 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.0 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.0 |
0.1 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.3 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.1 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.1 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.1 |
GO:0071105 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.0 |
0.0 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.0 |
0.2 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 |
0.1 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.0 |
0.0 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.0 |
0.1 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.0 |
0.2 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.0 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.0 |
0.0 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 |
0.0 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.1 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.0 |
0.1 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.1 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 |
0.0 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.0 |
0.0 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.0 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.0 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.0 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.2 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.0 |
GO:0072003 |
kidney rudiment formation(GO:0072003) |
| 0.0 |
0.2 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.4 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.0 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 |
0.1 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
